Previous 10 | Next 10 |
CANTON, Mass., April 12, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, t...
Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) traded today at $24.25, eclipsing its 52-week high. So far today approximately 414,000 shares have been exchanged, as compared to an average 30-day volume of 832,000 shares. Organogenesis Holdings Inc. (NASDAQ:ORGO) is currently priced ...
Organogenesis Holdings Inc. (ORGO) Q4 2020 Earnings Conference Call March 16, 2021, 05:00 PM ET Company Participants Gary Gillheeney - President and CEO Dave Francisco - CFO Conference Call Participants Matt Miksic - Credit Suisse Ryan Zimmerman - BTIG Richard Newitter - SVB Leerink Steven Li...
Image source: The Motley Fool. Organogenesis Holdings Inc (NASDAQ: ORGO) Q4 2020 Earnings Call Mar 16, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis Holdings Inc (ORGO) Q4 2020 Earnings Call Transcri...
Organogenesis Holdings (ORGO): Q4 GAAP EPS of $0.15 beats by $0.03.Revenue of $106.81M (+43.1% Y/Y) beats by $1.55M.Adjusted EBITDA of $24.9 million for the fourth quarter of 2020, compared to Adjusted EBITDA of $0.8 million for the fourth quarter of 2019, an increase of $24.1 million.Shares ...
CANTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, t...
CANTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, an...
Healthcare lagged the broader market last year, but that can change this year. A cyclical upturn as the pandemic abates and pent-up demand can boost healthcare. Best positioned are industry groups within healthcare that can achieve secular growth beyond the cyclical rise. Biot...
CANTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, toda...
CANTON, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...